Abstract
Demethylation at distinct lysine residues in histone H3 by lysine-specific demethylase 1 (LSD1) causes either gene repression or activation1,2. As a component of co-repressor complexes, LSD1 contributes to target gene repression by removing mono- and dimethyl marks from lysine 4 of histone H3 (H3K4)1,3. In contrast, during androgen receptor (AR)-activated gene expression, LSD1 removes mono- and dimethyl marks from lysine 9 of histone H3 (H3K9)2. Yet, the mechanisms that control this dual specificity of demethylation are unknown. Here we show that phosphorylation of histone H3 at threonine 6 (H3T6) by protein kinase C beta I (PKCβI, also known as PRKCβ) is the key event that prevents LSD1 from demethylating H3K4 during AR-dependent gene activation. In vitro, histone H3 peptides methylated at lysine 4 and phosphorylated at threonine 6 are no longer LSD1 substrates. In vivo, PKCβI co-localizes with AR and LSD1 on target gene promoters and phosphorylates H3T6 after androgen-induced gene expression. RNA interference (RNAi)-mediated knockdown of PKCβI abrogates H3T6 phosphorylation, enhances demethylation at H3K4, and inhibits AR-dependent transcription. Activation of PKCβI requires androgen-dependent recruitment of the gatekeeper kinase protein kinase C (PKC)-related kinase 1 (PRK1)4. Notably, increased levels of PKCβI and phosphorylated H3T6 (H3T6ph) positively correlate with high Gleason scores of prostate carcinomas, and inhibition of PKCβI blocks AR-induced tumour cell proliferation in vitro and cancer progression of tumour xenografts in vivo. Together, our data establish that androgen-dependent kinase signalling leads to the writing of the new chromatin mark H3T6ph, which in consequence prevents removal of active methyl marks from H3K4 during AR-stimulated gene expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941–953 (2004)
Metzger, E. et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437, 436–439 (2005)
Wang, Y. et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138, 660–672 (2009)
Metzger, E. et al. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nature Cell Biol. 10, 53–60 (2008)
Klose, R. J., Kallin, E. M. & Zhang, Y. JmjC-domain-containing proteins and histone demethylation. Nature Rev. Genet. 7, 715–727 (2006)
Wissmann, M. et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nature Cell Biol. 9, 347–353 (2007)
Yang, M. et al. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation. Nature Struct. Mol. Biol. 14, 535–539 (2007)
Forneris, F., Binda. C, Adamo, A., Battaglioli, E. & Mattevi, A. Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J. Biol. Chem. 282, 20070–20074 (2007)
Metzger, E. & Schüle, R. The expanding world of histone lysine demethylases. Nature Struct. Mol. Biol. 14, 252–254 (2007)
Kang, Z., Pirskanen, A., Janne, O. A. & Palvimo, J. J. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem. 277, 48366–48371 (2002)
Magee, J. A. et al. Direct, androgen receptor mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 147, 590–598 (2005)
Wang, Q. et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27, 380–392 (2007)
Makkonen, H. et al. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene 27, 4865–4876 (2008)
Keranen, L. M., Dutil, E. M. & Newton, A. C. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 5, 1394–1403 (1995)
Kang, Z., Jänne, O. A. & Palvimo, J. J. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18, 2633–2648 (2004)
Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumour specimens. Nature Med. 4, 844–847 (1998)
Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957–8961 (2003)
O’Neill, T. E., Roberge, M. & Bradbury, E. M. Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase. J. Mol. Biol. 223, 67–78 (1992)
Kahl, P. et al. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 66, 11341–11347 (2006)
Schröder, F. H. et al. The TNM classification of prostate cancer. Prostate Suppl. 21 129–138 (1992)
Hsing, A. W., Tsao, L. & Devesa, S. S. International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer 85, 60–67 (2000)
Tsukada, Y. et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439, 811–816 (2005)
Jensen, M. M., Jørgensen, J. T., Binderup, T. & Kjaer, A. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med. Imaging 8, 16 (2008)
Acknowledgements
We thank U. Elsäßer-Beile, K. Alt, U. Wetterauer, W. Schulze-Seelmann, R. Schneider, T. Waldmann, L. Heukamp, J. M. G. Higgins and N. Potier for providing reagents. We are obliged to A. Rieder, F. Pfefferle, L. Walz, L. Spady and J. Lauterwasser for technical assistance. This work was supported by grants of the Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt, SFB 746/P2, Schu 688/9-1, Dr. Hans Messner Stiftung, Dr. Oetker-Stiftung and SFB 832/Z1) to R.S. and R.B.
Author Contributions E.M., R.B. and R.S. designed this study, analysed the data and edited the manuscript. E.M., H.G., J.M.M. and T.G. performed experiments and edited the manuscript. A.I. performed mass spectrometry analysis. C.B.-H. synthesized reagents. D.P., P.K., K.H., N.F., N.K., S.J. and J.K. performed experiments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-22 with legends, and Supplementary References. (PDF 2891 kb)
Rights and permissions
About this article
Cite this article
Metzger, E., Imhof, A., Patel, D. et al. Phosphorylation of histone H3T6 by PKCβI controls demethylation at histone H3K4. Nature 464, 792–796 (2010). https://doi.org/10.1038/nature08839
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature08839
This article is cited by
-
Histone 3.3-related chromatinopathy: missense variants throughout H3-3A and H3-3B cause a range of functional consequences across species
Human Genetics (2023)
-
Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire
Cellular and Molecular Neurobiology (2023)
-
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1
Oncogene (2022)
-
Lysine-specific demethylase 1 as a corepressor of mineralocorticoid receptor
Hypertension Research (2022)
-
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
Oncogene (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.